Malaria Programme, World Health Organization

9:00am–10:10am

Pooled Safety of IPTi-SP

Sir Alasdair Breckenridge, M.D., M.Sc.

Chairman, UK Medicines and Healthcare Products Regulatory Agency

10:10am–10:20am

Break

10:20am–10:50am

Potential Impact of IPT on Spread of Drug-Resistant Malaria: Considerations from Mathematical Modeling

Wendy Prudhomme O’Meara, Ph.D.

Research Associate NIH/Fogarty Center, Centre for Geographic Medicine Research, KEMRI-Wellcome Trust Research Center, Kenya

10:50am–11:30am

Program Implementation Challenges in a Developing Country Context

Carol Medlin, Ph.D., M.P.A.

Professor, Anthropology and Social Medicine, University of California, San Francisco

11:30am–12:00pm

Kisumu—Results from First Trial of IPTi with Alternative Drugs to Sulfadoxine-Pyrimethamine

Larry Slutsker, M.D., M.P.H.

Chief, Malaria Branch of the U.S. Centers for Disease Control and Prevention

12:15pm–1:15pm

Lunch for Speakers and Registered Guests in Conference Room A

CLOSED LUNCH SESSION FOR COMMITTEE, Conference Room C

1:15pm–2:15pm

Open Question-and-Answer Session

2:15pm–2:55pm

Considerations for the Implementation of IPTi (by phone)

Brian Greenwood, M.D.

Manson Professor of Clinical Tropical Medicine, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine

2:55pm–3:52pm

Public Comment and Question Session

Concluding Remarks and Adjournment to Closed Sessions